Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News AnaptysBio Inc ANAB

Healthcare Biotechnology
AnaptysBio, Inc. is a clinical-stage biotechnology company focused on delivering immunology therapeutics. The Company is developing immune cell modulators, including two checkpoint agonists for autoimmune and inflammatory disease: rosnilimab, its PD-1 agonist, in a Phase 2b trial for the treatment of rheumatoid arthritis and in a Phase 2 trial for the treatment of ulcerative colitis; and ANB032... see more

Recent & Breaking News (NDAQ:ANAB)

ANAB LOSS NOTICE: ROSEN, A TOP RANKED LAW FIRM, Announces Filing of Securities Class Action Lawsuit Against AnaptysBio, Inc.; Encourages Investors with Large Losses to Contact Firm - ANAB

GlobeNewswire March 31, 2020

CLASS ACTION UPDATE for CRON, ANAB and HAFC: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

ACCESSWIRE IA March 31, 2020

ANAPTYSBIO DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 in AnaptysBio, Inc. to Contact the Firm

Business Wire March 30, 2020

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of CCI, ALGN and ANAB

ACCESSWIRE IA March 30, 2020

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages AnaptysBio (ANAB) Investors Who Have Suffered Losses to Contact its Attorneys: Securities Fraud Class Action Filed

ACCESSWIRE IA March 30, 2020

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of SSL, ANAB and HAFC

ACCESSWIRE IA March 30, 2020

ANAB SHAREHOLDER UPDATE: Bronstein, Gewirtz & Grossman, LLC Notifies AnaptysBio, Inc. Shareholders of Class Action and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

GlobeNewswire March 30, 2020

IMPORTANT INVESTOR NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AnaptysBio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

ACCESSWIRE IA March 30, 2020

SHAREHOLDER ALERT: SSL JELD ANAB: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

ACCESSWIRE IA March 30, 2020

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AnaptysBio, Inc. - ANAB

GlobeNewswire March 30, 2020

ANAB SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies AnaptysBio, Inc. Shareholders of Class Action and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

ACCESSWIRE IA March 30, 2020

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of HPQ, CAN and ANAB

ACCESSWIRE IA March 29, 2020

IMPORTANT SHAREHOLDER ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AnaptysBio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

ACCESSWIRE IA March 28, 2020

ANAB ALERT: ROSEN, GLOBAL INVESTOR COUNSEL, Announces Filing of Securities Class Action Lawsuit Against AnaptysBio, Inc. - ANAB

PR Newswire March 27, 2020

Glancy Prongay & Murray LLP Announces the Filing of a Securities Class Action on Behalf of AnaptysBio, Inc. (ANAB) Investors

Business Wire March 27, 2020

INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf AnaptysBio, Inc. (ANAB) Investors

Business Wire March 27, 2020

SHAREHOLDER ALERT: CCI TLRY ANAB: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

ACCESSWIRE IA March 27, 2020

Shareholder Alert: Robbins LLP Announces AnaptysBio, Inc. (ANAB) Sued for Misleading Shareholders

Business Wire March 27, 2020

IMPORTANT INVESTOR NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AnaptysBio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

ACCESSWIRE IA March 27, 2020

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of WBK, CCI and ANAB

ACCESSWIRE IA March 27, 2020